Microport Cardioflow Medtech Corp
Microport Cardioflow Medtech's GHG Emissions Data Preview
In 2023, Microport Cardioflow Medtech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Microport Cardioflow Medtech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Microport Cardioflow Medtech’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Microport Cardioflow Medtech’s data sources below and access millions more through our Disclosure Search.
Insights into Microport Cardioflow Medtech's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Microport Cardioflow Medtech amounted to 3,345.9 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Microport Cardioflow Medtech decreased by 39.25%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Microport Cardioflow Medtech's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Microport Cardioflow Medtech's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Microport Cardioflow Medtech were 267.5 metric tons of CO₂ equivalent (tCO₂e). a
Has Microport Cardioflow Medtech reduced its Scope 1 emissions over time?
Since 2020, Microport Cardioflow Medtech's Scope 1 emissions have increased by 5,702.6%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Microport Cardioflow Medtech's Scope 1 emissions decreased by 23.22%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Microport Cardioflow Medtech's Scope 2 emissions?
In 2023, Microport Cardioflow Medtech reported Scope 2 greenhouse gas (GHG) emissions of 3,078.4 tCO₂e without specifying the calculation method. a
Has Microport Cardioflow Medtech reduced its Scope 2 emissions over time?
Since 2020, Microport Cardioflow Medtech's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 23.83%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2022), Microport Cardioflow Medtech's Scope 2 emissions (Unspecified Calculation Method) fell by 40.34% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a
What methodology does Microport Cardioflow Medtech use for Scope 2 reporting?
In 2023, Microport Cardioflow Medtech reported its Scope 2 emissions using an unspecified methodology. a
Microport Cardioflow Medtech's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Microport Cardioflow Medtech’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Microport Cardioflow Medtech reported Scope 1 greenhouse gas (GHG) emissions of 267.5 tCO₂e and total revenues of USD 52 millions. This translates into an emissions intensity of 5.18 tCO₂e per millions USD. a
Microport Cardioflow Medtech's Scope 1 Emissions Intensity Compared to Peers
How does Microport Cardioflow Medtech's GHG emissions intensity compare to its peers?
In 2023, Microport Cardioflow Medtech reported a Scope 1 emissions intensity of 5.18 tCO₂e per millions USD. Compared to the peer group median of 4.28 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Microport Cardioflow Medtech rank on GHG emissions intensity within its industry?
In 2023, Microport Cardioflow Medtech ranked 14 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Microport Cardioflow Medtech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a